MedTrace Logo

NeuroStar TMS Therapy System: Utilization and Outcomes

NCT01114477 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 307

Last updated 2015-11-13

No results posted yet for this study

Summary

The major objective of this observational study is to describe clinical outcomes of patients receiving treatment with the NeuroStar TMS Therapy system in routine clinical practice.

Conditions

Sponsors & Collaborators

  • Neuronetics

    lead OTHER

Principal Investigators

  • Mark Demitrack, MD · Neuronetics, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01114477 on ClinicalTrials.gov